Your browser doesn't support javascript.
loading
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast Cancer.
Whittle, James R; Vaillant, François; Surgenor, Elliot; Policheni, Antonia N; Giner, Göknur; Capaldo, Bianca D; Chen, Huei-Rong; Liu, He K; Dekkers, Johanna F; Sachs, Norman; Clevers, Hans; Fellowes, Andrew; Green, Thomas; Xu, Huiling; Fox, Stephen B; Herold, Marco J; Smyth, Gordon K; Gray, Daniel H D; Visvader, Jane E; Lindeman, Geoffrey J.
  • Whittle JR; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Vaillant F; Department of Medical Oncology, The Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Surgenor E; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Policheni AN; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Giner G; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Capaldo BD; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Chen HR; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Liu HK; Immunology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Dekkers JF; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Sachs N; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Clevers H; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Fellowes A; Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Green T; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Xu H; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Fox SB; Cancer Biology and Stem Cells Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Herold MJ; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands.
  • Smyth GK; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Gray DHD; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands.
  • Visvader JE; Oncode Institute, Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC), Utrecht, the Netherlands.
  • Lindeman GJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Clin Cancer Res ; 26(15): 4120-4134, 2020 08 01.
Article en En | MEDLINE | ID: mdl-32245900
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-bcl-2 / Terapia Neoadyuvante / Inhibidores de Proteínas Quinasas Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogénicas c-bcl-2 / Terapia Neoadyuvante / Inhibidores de Proteínas Quinasas Idioma: En Año: 2020 Tipo del documento: Article